VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ALXO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ALXOALX Oncology Holdings Inc.
$1.00$135M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksALXOQuarterly Cash Flow

ALX Oncology Holdings Inc. (ALXO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ALX Oncology Holdings Inc. (ALXO) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

ALXO Cash Flow Statement

Quarterly statement

ALXO Cash Flow Statement

ALX Oncology Holdings Inc. (ALXO) cash flow statement — 8-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-14.74M-16.06M-18.65M-18.98M-17.09M-23.41M-24.66M-32.05M-25.38M-26.57M-37.92M-39.68M-31.16M-31.71M-27.82M-20.67M-30.88M-17M-20.67M-17.49M
Operating CF Margin %--------------------
Operating CF Growth %13.77%31.4%24.39%40.77%32.64%11.89%34.97%19.23%18.56%16.22%-36.34%-91.98%-0.89%-86.56%-34.55%-18.18%-24.25%17.57%-302.61%-28.45%
Net Income-21.83M-17.97M-17.93M-22.85M-22.14M-25.95M-30.75M-29.16M-30.71M-39.4M-35.58M-45.47M-50.99M-34.16M-30.18M-30.71M-35.32M-32.92M-24.53M-28.44M
Depreciation & Amortization56K86K150K151K153K191K211K214K224K220K214K207K209K513K213K413K397K280K376K34K
Stock-Based Compensation2.89M2.68M2.51M2.71M2.52M2.14M5.22M5.86M6.95M7.25M7.03M6.72M6.96M06.35M00005.69M
Deferred Taxes00000000000-11.62M-1.84M0000000
Other Non-Cash Items1.01M-1.37M257K272K253K3.39M19K-195K-523K-849K-1.03M10.15M372K4.65M-748K5.66M5.85M5.83M5.61M4.96M
Working Capital Changes3.12M513K-3.64M739K2.12M-3.17M645K-8.76M-1.32M6.21M-8.56M331K14.13M-2.71M-3.45M3.97M-1.81M9.81M-2.13M266K
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables1.05M-765K-1.21M-1.67M1.68M965K-556K-3.78M-194K1.88M-2.33M-4.48M8.89M-5.71M1.77M2.45M-3.06M3.56M1.55M-330K
Cash from Investing19.24M6.52M-105.04M11.23M21.39M22.32M27.64M33.18M25.69M907K26.47M-16.67M12.81M6.21M42.3M10.94M13.7M-76.13M-183.92M-4.52M
Capital Expenditures-65K-17K-50K-49K-56K-47K-60K-60K-149K-90K-148K-148K1.3M-1.74M-690K-389K-192K-257K-589K-261K
CapEx % of Revenue--------------------
Acquisitions0000000000050.94K00000000
Investments--------------------
Other Investing129K44K000000000-50.94K0000000-4.26M
Cash from Financing8.2M137K139.59M678K-159K-222K65K328K251K27.15M3.09M59.17M-111K343K-107K9.49M-136K422K80K524K
Debt Issued (Net)0284K-1.61M-660K-160K-237K-307K-76K-358K-218K-175K-63K-111K-107K-107K9.24M-141K-35K-105K-104K
Equity Issued (Net)0107K141.21M1.34M1K15K372K-29.3M75K26.2M3.02M59.23M0450K0256K5K457K185K-103K
Dividends Paid00000000000000000000
Share Repurchases31K0000000000000000000
Other Financing8.2M-254K0000029.71M534K1.17M237K00000000731K
Net Change in Cash12.7M-9.4M15.91M-7.07M4.14M-1.31M3.05M1.47M568K1.49M-8.37M2.82M-18.45M-25.16M14.37M-232K-17.32M-92.71M-204.58M-21.48M
Free Cash Flow-14.8M-16.07M-18.7M-19.03M-17.15M-23.45M-24.72M-32.11M-25.52M-26.66M-38.07M-39.83M-29.86M-33.45M-28.51M-21.06M-31.07M-17.25M-21.26M-22.01M
FCF Margin %--------------------
FCF Growth %13.67%31.46%24.37%40.73%32.81%12.02%35.06%19.38%14.51%20.31%-33.56%-89.13%3.92%-93.86%-34.06%4.31%-23.05%16.33%-313.52%-61.5%
FCF per Share-0.11-0.12-0.18-0.35-0.32-0.44-0.46-0.61-0.48-0.51-0.76-0.81-0.73-0.82-0.70-0.52-0.76-0.42-0.52-0.54
FCF Conversion (FCF/Net Income)0.68x0.89x1.04x0.83x0.77x0.90x0.80x1.10x0.83x0.67x1.07x0.87x0.61x0.93x0.92x0.67x0.87x0.52x0.84x0.61x
Interest Paid00000000000000000004K
Taxes Paid00000000000000000000